Cannabis culture: Cronos buys 102,000 L microbial plant from Apotex
The facility in Winnipeg, Canada will be used to produce cell cultured cannabinoids through its collaboration with Ginkgo Bioworks, says Cronos Group. Cannabinoid company Cronos Group has agreed to buy Apotex Fermentation Inc’s 84,000 square-foot biomanufacturing factory in Winnipeg for an undi ...
The acquisition will be the latest boost for Boehringer Ingelheim in the immune cell-directed therapy space, adding a fusion protein platform and ...
ADC Bio has completed construction of a cleanroom in Wales, part of an $11 million bioconjugation facility set to serve the robust demand for ant ...
IDT Biologika will manufacture five E. coli Master Cell Banks from its Maryland site to support a pentavalent vaccine for the National Institutes ...
CDMO Catalent’s unit Paragon will construct a dedicated manufacturing suite in Maryland to service Passage Bio’s clinical and commercial gene ...
Recent Tweets
-
RT @Dan5tanton: ADC Bio has completed construction of a cleanroom in Wales, part of an $11m bioconjugation facility to serve demand… https://t.co/8ONhj1Js3U
3 hours ago
-
MT @Bioprocess365: The future is bright for antibody & cellular immunotherapies, with bispecifics and CAR Ts conver… https://t.co/GJl0DpXjLK
19 hours ago
-
RT @HardEdgeIndustr: Amgen Breaks Ground On Next-Generation Biomanufacturing Plant In Rhode Island
https://t.co/6CBzIICuVS
19 hours ago
-
MT @Dan5tanton: The Apotex facility in Winnipeg, Canada will be used to produce cell cultured cannabinoids through… https://t.co/Ckq9yUYptl
3 days ago
Trending
Analytical
Biopharmaceutical Characterization, Part 2: Applications and Strategies for Diverse Products — A Conference Report
Manufacturing
Manufacturing of Cell and Gene Therapies
Manufacturing
eBook: Allogeneic Cell Therapies Commercialization Strategies
Manufacturing
Immunotherapy: Taking Aim at Solid Cancers